Pathway transformation
Pathway transformation projects within the NHS allow teams to rapidly integrate new technology into care pathways.
The Genomic Medicine Service Alliance works closely with NHS Trusts, charities and industry partners across the country to bring new genomic tests and technologies to patients. We work with patients and families throughout ensuring their views are incorporated and heard at every stage.
Circulating tumour DNA
Liquid biopsy tests, also known as circulating tumour DNA (ctDNA) tests, sequence fragments of tumour DNA that are released into the blood stream.
Sudden Cardiac Death
When someone dies suddenly, this can be due to a genetic cause, meaning relatives may also be at risk. Gold standard care is to recommend genetic testing on the loved-one who died and offer clinical screening to relatives.
Jewish BRCA testing
BRCA refers to two genes, BRCA1 and BRCA2, that everyone possesses, these genes help repair damaged DNA. People carrying a BRCA1 or BRCA2 with specific variant changes have an increased risk of developing several cancers, in particular breast, ovarian and pancreatic cancer.
